{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:40Z","timestamp":1792788580956,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universitat de Valencia","id":[{"id":"https:\/\/ror.org\/043nxc105","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pelvic exenteration (PE) is a radical surgical option for locally advanced or recurrent gynecologic cancers, but its contemporary risk\u2013benefit profile has never been systematically compared with the original Brunschwig experience. The purpose of the study was to quantify changes in major postoperative morbidity, perioperative mortality, and oncologic outcomes after PE between Brunschwig-era series (1954\u20131969) and contemporary series (1990\u20132024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>This was an International Prospective Register of Systematic Reviews (PROSPERO)-registered (CRD420251009209) systematic review and meta-analysis. PubMed\/MEDLINE, Web of Science, and Scopus were searched through December 2024 for studies reporting complications, mortality, or survival after pelvic exenteration for gynecologic malignancies. Two reviewers independently performed study selection and data extraction. Major morbidity was harmonized to Clavien\u2013Dindo grade III or higher (or equivalent). Random-effects meta-analyses were performed where appropriate. All eligible studies identified were retrospective series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 34 studies (5478 patients; 913 historical and 4565 contemporary) were included. Major morbidity decreased from 58% (95% CI 46\u201368%) in historical series to 23% (95% CI 17\u201331%) in contemporary series, while perioperative mortality declined from 23 (95% CI 17\u201330%) to 3% (95% CI 2\u20134%). Contemporary series also reported improved oncologic outcomes, although heterogeneity and differences in follow-up precluded direct survival comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with the original Brunschwig era, contemporary pelvic exenteration is associated with substantially lower major morbidity and perioperative mortality, together with improved oncologic outcomes. These findings illustrate the remarkable technical and conceptual evolution of pelvic exenteration over the past seven decades, although direct comparisons between historical and contemporary series should be interpreted cautiously because of differences in patient selection and clinical practice over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20498-3","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:36:26Z","timestamp":1791549386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Historical Evolution of Pelvic Exenteration Surgery in Gynecologic Cancers: A Systematic Review and Meta-Analysis of Brunschwig\u2019s Era versus Contemporary Practice"],"prefix":"10.1245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-9975","authenticated-orcid":false,"given":"Alberto Rafael","family":"Guijarro-Campillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"S\u00e1nchez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"20498_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:23.0.CO;2-A","volume":"1","author":"A Brunschwig","year":"1948","unstructured":"Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1:177\u201383. https:\/\/doi.org\/10.1002\/1097-0142(194807)1:23.0.CO;2-A.","journal-title":"Cancer"},{"issue":"3","key":"20498_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0002-9378(16)38316-8","volume":"68","author":"A Brunschwig","year":"1954","unstructured":"Brunschwig A. What can surgery accomplish in recurrent carcinoma of the cervix? Am J Obstetr and Gynecol. 1954;68(3):776\u201380.","journal-title":"Am J Obstetr and Gynecol"},{"key":"20498_CR3","doi-asserted-by":"publisher","first-page":"153Y159","DOI":"10.1016\/j.ygyno.2005.05.034","volume":"99","author":"JS Berek","year":"2005","unstructured":"Berek JS, Howe C, Lagasse LD, et al. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99:153Y159.","journal-title":"Gynecol Oncol."},{"key":"20498_CR4","doi-asserted-by":"publisher","first-page":"476Y484","DOI":"10.1002\/jso.20686","volume":"95","author":"MC Fleisch","year":"2007","unstructured":"Fleisch MC, Pantke P, Beckmann MW, et al. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J Surg Oncol. 2007;95:476Y484.","journal-title":"J Surg Oncol."},{"key":"20498_CR5","doi-asserted-by":"publisher","first-page":"e59Ye66","DOI":"10.1016\/j.suronc.2011.12.008","volume":"21","author":"M Peiretti","year":"2012","unstructured":"Peiretti M, Zapardiel I, Zanagnolo V, et al. Management of recurrent cervical cancer a review of the literature. Surg Oncol. 2012;21:e59Ye66. https:\/\/doi.org\/10.1016\/j.suronc.2011.12.008.","journal-title":"Surg Oncol."},{"key":"20498_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/CCO.0000000000000109","volume":"26","author":"M Kaur","year":"2014","unstructured":"Kaur M, Joniau S, D\u2019Hoore A, Vergote I, et al. Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy. Curr Opin Oncol. 2014;26:514\u201320.","journal-title":"Curr Opin Oncol"},{"issue":"9","key":"20498_CR7","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/IGC.0000000000001371","volume":"28","author":"S MacLaughlan David","year":"2018","unstructured":"MacLaughlan David S, Marjon N, English D, et al. Palliative total pelvic exenteration for gynecologic cancers: a cross-sectional study of society of gynecologic oncology members. Int J Gynecol Cancer. 2018;28(9):1796\u2013804.","journal-title":"Int J Gynecol Cancer."},{"issue":"12","key":"20498_CR8","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/j.ejso.2019.07.015","volume":"45","author":"PS Waters","year":"2019","unstructured":"Waters PS, Peacock O, Warrier SK, Wakeman C, Eglinton T, Lynch AC, Frizelle FA, Heriot AG, McCormick J. Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades. Eur J Surg Oncol. 2019;45(12):2325\u201333.","journal-title":"Eur J Surg Oncol."},{"key":"20498_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"20498_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/gyno.1996.4532","volume":"64","author":"JF Magrina","year":"1997","unstructured":"Magrina JF, Stanhope CR, Weaver AL, et al. Pelvic exenterations: suprale- vator, infralevator, and with vulvectomy. Gynecol Oncol. 1997;64:130\u20135.","journal-title":"Gynecol Oncol."},{"key":"20498_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA, et al. Classification of surgical compli- cations: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"20498_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/SLA.0b013e3181afde41","volume":"250","author":"SM Strasberg","year":"2009","unstructured":"Strasberg SM, Linehan DC, Hawkins WG, et al. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177.","journal-title":"Ann Surg"},{"issue":"4","key":"20498_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1245\/s10434-014-4141-4","volume":"22","author":"VE Strong","year":"2015","unstructured":"Strong VE, Selby LV, Sovel M, et al. Development and assessment of memorial Sloan kettering cancer center\u2019s surgical secondary events grading system. Ann Surg Oncol. 2015;22(4):1061\u20137.","journal-title":"Ann Surg Oncol."},{"key":"20498_CR14","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et. al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford 2000"},{"key":"20498_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"20498_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805.","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"20498_CR17","first-page":"324","volume":"99","author":"A Brunschwig","year":"1954","unstructured":"Brunschwig A, Daniel W. Total and anterior pelvic exenteration I Report of results based upon 315 operations. Surg Gynecol Obstet. 1954;99(3):324\u201330.","journal-title":"Surg Gynecol Obstet"},{"issue":"3","key":"20498_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0002-9378(56)90370-2","volume":"72","author":"A Brunschwig","year":"1956","unstructured":"Brunschwig A, Daniel W. Pelvic exenterations for advanced carcinoma of the vulva. Am J Obstet Gynecol. 1956;72(3):489\u201396.","journal-title":"Am J Obstet Gynecol."},{"key":"20498_CR19","first-page":"575","volume":"25","author":"HR Barber","year":"1965","unstructured":"Barber HR, Brunschwig A. Pelvic exenteration for extensive visceral necrosis following radiation therapy for gynecologic cancer. Obstet Gynecol. 1965;25:575\u20138 (PMID: 14268049).","journal-title":"Obstet Gynecol."},{"issue":"6","key":"20498_CR20","first-page":"935","volume":"58","author":"HR Barber","year":"1965","unstructured":"Barber HR, Brunschwig A. Pelvic exenteration for locally advanced and recurrent ovarian cancer Review of 22 cases. Surgery. 1965;58(6):935\u20137.","journal-title":"Surgery"},{"issue":"6","key":"20498_CR21","first-page":"754","volume":"28","author":"HR Barber","year":"1966","unstructured":"Barber HR, Brunschwig A. Urinary tract fistulas following pelvic exenteration. Obstet Gynecol. 1966;28(6):754\u201363.","journal-title":"Obstet Gynecol."},{"issue":"1","key":"20498_CR22","first-page":"21","volume":"27","author":"A Brunschwig","year":"1966","unstructured":"Brunschwig A, Barber HR. Surgical treatment of carcinoma of the cervix. Obstet Gynecol. 1966;27(1):21\u20139.","journal-title":"Obstet Gynecol."},{"issue":"2","key":"20498_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2214\/ajr.99.2.365","volume":"99","author":"A Brunschwig","year":"1967","unstructured":"Brunschwig A. Surgical treatment of carcinoma of the cervix, recurrent after irradiation or combination of irradiation and surgery. Am J Roentgenol Radium Ther Nucl Med. 1967;99(2):365\u201370.","journal-title":"Am J Roentgenol Radium Ther Nucl Med."},{"issue":"5","key":"20498_CR24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/1097-0142(196811)22:5<949::AID-CNCR2820220509>3.0.CO;2-7","volume":"22","author":"HR Barber","year":"1968","unstructured":"Barber HR, Brunschwig A. Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration 1947\u20131963. Cancer. 1968;22(5):949\u201355.","journal-title":"Cancer."},{"issue":"3","key":"20498_CR25","first-page":"417","volume":"65","author":"A Brunschwig","year":"1969","unstructured":"Brunschwig A, Barber HR. Pelvic exenteration combined with resection of segments of bony pelvis. Surgery. 1969;65(3):417\u201320.","journal-title":"Surgery."},{"issue":"1","key":"20498_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","volume":"114","author":"A Maggioni","year":"2009","unstructured":"Maggioni A, Roviglione G, Landoni F, Zanagnolo V, Peiretti M, Colombo N, Bocciolone L, Biffi R, Minig L, Morrow CP. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114(1):64\u20138.","journal-title":"Gynecol Oncol."},{"issue":"6","key":"20498_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/jso.21518","volume":"101","author":"C Fotopoulou","year":"2010","unstructured":"Fotopoulou C, Neumann U, Kraetschell R, Schefold JC, Weidemann H, Lichtenegger W, Sehouli J. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies. J Surg Oncol. 2010;101(6):507\u201312.","journal-title":"J Surg Oncol."},{"issue":"1","key":"20498_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","volume":"122","author":"T Benn","year":"2011","unstructured":"Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol. 2011;122(1):14\u20138.","journal-title":"Gynecol Oncol."},{"issue":"4","key":"20498_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3802\/jgo.2012.23.4.242","volume":"23","author":"HJ Yoo","year":"2012","unstructured":"Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol. 2012;23(4):242\u201350.","journal-title":"J Gynecol Oncol."},{"issue":"1","key":"20498_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/IGC.0000000000000011","volume":"24","author":"V Chiantera","year":"2014","unstructured":"Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Fagotti A, Fanfani F, Parazzini F, Schiavina R, Scambia G, Schneider A, Vercellino GF. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer. 2014;24(1):156\u201364.","journal-title":"Int J Gynecol Cancer."},{"issue":"3","key":"20498_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","volume":"134","author":"SN Westin","year":"2014","unstructured":"Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134(3):546\u201351.","journal-title":"Gynecol Oncol."},{"issue":"5","key":"20498_CR32","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e68","volume":"29","author":"RJ Jalloul","year":"2018","unstructured":"Jalloul RJ, Nick AM, Munsell MF, Westin SN, Ramirez PT, Frumovitz M, Soliman PT. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol. 2018;29(5):e68.","journal-title":"J Gynecol Oncol."},{"issue":"13","key":"20498_CR33","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.4103\/0366-6999.235111","volume":"131","author":"L Li","year":"2018","unstructured":"Li L, Ma SQ, Tan XJ, Zhong S, Wu M. Pelvic exenteration for recurrent and persistent cervical cancer. Chin Med J (Engl). 2018;131(13):1541\u20138.","journal-title":"Chin Med J (Engl)."},{"issue":"2","key":"20498_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.acuro.2017.05.004","volume":"42","author":"A Romeo","year":"2018","unstructured":"Romeo A, Gonzalez MI, Jaunarena J, Zubieta ME, Favre G, Tejerizo JC. Pelvic exenteration for gynecologic malignancies: postoperative complications and oncologic outcomes. Actas Urol Esp. 2018;42(2):121\u20135.","journal-title":"Actas Urol Esp."},{"issue":"7","key":"20498_CR35","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jmig.2018.12.019","volume":"26","author":"N Bizzarri","year":"2019","unstructured":"Bizzarri N, Chiantera V, Ercoli A, Fagotti A, Tortorella L, Conte C, Cappuccio S, Di Donna MC, Gallotta V, Scambia G, Vizzielli G. Minimally invasive pelvic exenteration for gynecologic malignancies: a multi-institutional case series and review of the literature. J Minim Invasive Gynecol. 2019;26(7):1316\u201326.","journal-title":"J Minim Invasive Gynecol."},{"issue":"1","key":"20498_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00404-019-05154-4","volume":"300","author":"N de Gregorio","year":"2019","unstructured":"de Gregorio N, de Gregorio A, Ebner F, Friedl TWP, Huober J, Hefty R, Wittau M, Janni W, Widschwendter P. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases. Arch Gynecol Obstet. 2019;300(1):161\u20138.","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"20498_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ygyno.2019.02.002","volume":"153","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Mandelbaum RS, Adams CL, Roman LD, Wright JD. Performance and outcome of pelvic exenteration for gynecologic malignancies: a population-based study. Gynecol Oncol. 2019;153(2):368\u201375.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"20498_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2018.10.036","volume":"152","author":"L Tortorella","year":"2019","unstructured":"Tortorella L, Casarin J, Mara KC, Weaver AL, Multinu F, Glaser GE, Cliby WA, Scambia G, Mariani A, Kumar A. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol. 2019;152(1):151\u20136.","journal-title":"Gynecol Oncol."},{"issue":"5","key":"20498_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/gyn.2019.0145","volume":"36","author":"N Kimmich","year":"2020","unstructured":"Kimmich N, Egger H, Schneider S, Schmidt AM. Pelvic exenteration for primary advanced and recurrent vaginal cancer: clinical outcome for 37 patients. J Gynecol Surg. 2020;36(5):244\u20139.","journal-title":"J Gynecol Surg."},{"issue":"1","key":"20498_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12957-020-01997-3","volume":"18","author":"A Lewandowska","year":"2020","unstructured":"Lewandowska A, Szubert S, Koper K, Koper A, Cwynar G, Wicherek L. Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer. World J Surg Oncol. 2020;18(1):234.","journal-title":"World J Surg Oncol."},{"issue":"6","key":"20498_CR41","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1245\/s10434-020-09207-w","volume":"28","author":"G Vizzielli","year":"2021","unstructured":"Vizzielli G, Tortorella L, Conte C, Chiantera V, Gallotta V, Foschi N, Arcieri M, Ferrandina G, Fagotti A, Zattoni F, Scambia G, Ercoli A. Is a vaginectomy enough or is a pelvic exenteration always required for surgical treatment of recurrent cervical cancer? A propensity-matched study. Ann Surg Oncol. 2021;28(6):3281\u201390.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"20498_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3892\/etm.2021.10494","volume":"22","author":"M Gheorghe","year":"2021","unstructured":"Gheorghe M, Cozlea AL, Kiss SL, Stanca M, C\u0103p\u00eelna ME, Bacalba\u0219a N, Moldovan AA. Primary pelvic exenteration: our experience with 23 patients from a single institution. Exp Ther Med. 2021;22(4):1060.","journal-title":"Exp Ther Med."},{"issue":"1","key":"20498_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29337\/ijsonco.24","volume":"6","author":"P Matylevich Olga","year":"2021","unstructured":"Matylevich Olga P, Schmeler Kathleen M, Polyakov Sergey L, Mavrichev Siarhei A, Kosenko Irina A, Krasny Sergei A. Pelvic exenteration in patients with persistent and recurrent cervical cancer: a case series from Belarus. IJS Oncol. 2021;6(1):1\u20139.","journal-title":"IJS Oncol"},{"issue":"3","key":"20498_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.21873\/cdp.10110","volume":"2","author":"LT Glane","year":"2022","unstructured":"Glane LT, Hegele A, Wagner U, Boekhoff J. Gynecologic oncology: pelvic exenteration for advanced or recurring cervical cancer - a single center analysis. Cancer Diagn Progn. 2022;2(3):308\u201315.","journal-title":"Cancer Diagn Progn."},{"issue":"1","key":"20498_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s13224-021-01502-0","volume":"72","author":"I Bouraoui","year":"2022","unstructured":"Bouraoui I, Bouaziz H, Tounsi N, Ben Romdhane R, Hechiche M, Slimane M, Rahal K. Survival after pelvic exenteration for cervical cancer. J Obstet Gynaecol India. 2022;72(1):66\u201371.","journal-title":"J Obstet Gynaecol India."},{"key":"20498_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101702","volume":"40","author":"D Haidopoulos","year":"2022","unstructured":"Haidopoulos D, Pergialiotis V, Aggelou K, Thomakos N, Alexakis N, Stamatakis E, Rodolakis A. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece. Surg Oncol. 2022;40:101702.","journal-title":"Surg Oncol."},{"issue":"9","key":"20498_CR47","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/cancers14092346","volume":"14","author":"M Stanca","year":"2022","unstructured":"Stanca M, C\u0103p\u00eelna DM, C\u0103p\u00eelna ME. Long-term survival, prognostic factors, and quality of life of patients undergoing pelvic exenteration for cervical cancer. Cancers (Basel). 2022;14(9):2346.","journal-title":"Cancers (Basel)."},{"key":"20498_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2023.02.010","volume":"171","author":"LR Moolenaar","year":"2023","unstructured":"Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, van Driel WJ, van Lonkhuijzen LRCW, Mom CH, Zaal A. Clinical outcomes of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2023;171:114\u201320.","journal-title":"Gynecol Oncol."},{"key":"20498_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejogrb.2023.01.022","volume":"282","author":"V Lago","year":"2023","unstructured":"Lago V, Pradillo Aramendi T, Segarra-Vidal B, Padilla-Iserte P, Matute L, Gurrea M, Pontones JL, Delgado F, Domingo S. Comparation between the Bricker ileal conduit vs double-barrelled wet colostomy after pelvic exenteration for gynaecological malignancies. Eur J Obstet Gynecol Reprod Biol. 2023;282:140\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"5","key":"20498_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/AOG.0000000000006051","volume":"146","author":"N Bizzarri","year":"2025","unstructured":"Bizzarri N, Querleu D, Ricotta G, et al. Complications and recurrence after pelvic exenteration for gynecologic malignancies: survival analysis from the COREPEX study. Obstet Gynecol. 2025;146(5):737\u201349.","journal-title":"Obstet Gynecol."},{"issue":"2","key":"20498_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.102820","volume":"36","author":"N Bizzarri","year":"2026","unstructured":"Bizzarri N, Querleu D, Ricotta G, et al. Complications and recurrence after pelvic exenteration for gynecologic malignancies: analysis of surgical complications from the COREPEX study. Int J Gynecol Cancer. 2026;36(2):102820.","journal-title":"Int J Gynecol Cancer."},{"issue":"1","key":"20498_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.urolonc.2004.07.018","volume":"23","author":"M Wilkin","year":"2005","unstructured":"Wilkin M, Horwitz G, Seetharam A, Hartenbach E, Schink JC, Bruskewitz R, Jarrard DF. Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation. Urol Oncol. 2005;23(1):12\u20135.","journal-title":"Urol Oncol."},{"key":"20498_CR53","doi-asserted-by":"crossref","unstructured":"Ramirez PT, Cibula D. Principles of gynecologic oncology surgery. Princ Gynecol Oncol Surg. 2019. :193\u2013206","DOI":"10.1016\/B978-0-323-42878-1.00015-8"},{"key":"20498_CR54","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ygyno.2007.04.030","volume":"106","author":"KN Moore","year":"2007","unstructured":"Moore KN, Gold MA, McMeekin DS, Zorn KK. Vesicovaginal fistula formation in patients with stage IVA cervical carcinoma. Gynecol Oncol. 2007;106:498\u2013501.","journal-title":"Gynecol Oncol"},{"key":"20498_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ygyno.2013.02.038","volume":"130","author":"F Landoni","year":"2013","unstructured":"Landoni F, Zanagnolo V, Rosenberg PG, et al. Neoadjuvant chemo- therapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience. Gynecol Oncol. 2013;130:69\u201374.","journal-title":"Gynecol Oncol"},{"key":"20498_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijgo.13867","volume":"155","author":"TS Adams","year":"2021","unstructured":"Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet. 2021;155:19\u201327.","journal-title":"Int J Gynaecol Obstet."},{"key":"20498_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijgo.13881","volume":"155","author":"AB Olawaiye","year":"2021","unstructured":"Olawaiye AB, Cuello MA, Rogers LJ. Cancer of the vulva: 2021 update. Int J Gynaecol Obstet. 2021;155:7\u201318. https:\/\/doi.org\/10.1002\/ijgo.13881.","journal-title":"Int J Gynaecol Obstet."},{"key":"20498_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/gyno.1999.5536","volume":"75","author":"RR Barakat","year":"1999","unstructured":"Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol. 1999;75:99\u2013102.","journal-title":"Gynecol Oncol."},{"key":"20498_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/gyno.1996.0040","volume":"60","author":"M Morris","year":"1996","unstructured":"Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol. 1996;60:288\u201391.","journal-title":"Gynecol Oncol."},{"key":"20498_CR60","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/IGC.0000000000000002","volume":"24","author":"V Chiantera","year":"2014","unstructured":"Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Gallotta V, Margariti AP, Parazzini F, Scambia G, Schneider A, et al. Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients. Int J Gynecol Cancer. 2014;24:880\u20134.","journal-title":"Int J Gynecol Cancer."},{"issue":"7447","key":"20498_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2023","unstructured":"Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Cancer genome atlas research network integrated genomic characterization of endometrial carcinoma. Nature. 2023;497(7447):67\u201373.","journal-title":"Nature."},{"key":"20498_CR62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/00016345909153956","volume":"38","author":"E Odeblad","year":"1959","unstructured":"Odeblad E. Research in obstetrics and gynaecology with nuclear magnetic resonance. Acta Obstet Gynecol Scand. 1959;38:599\u2013617.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"6","key":"20498_CR63","first-page":"1027","volume":"73","author":"HM Shingleton","year":"1989","unstructured":"Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989;73(6):1027\u201334.","journal-title":"Obstet Gynecol."},{"key":"20498_CR64","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0022-5347(17)41210-9","volume":"141","author":"MF Carter","year":"1989","unstructured":"Carter MF, Dalton DP, Garnett JE. Simultaneous diversion of the urinary and fecal streams utilizing a single abdominal stoma: the double-barreled wet colostomy. J Urol. 1989;141:1189\u201391.","journal-title":"J Urol"},{"issue":"6","key":"20498_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.surge.2023.03.004","volume":"21","author":"JP Wright","year":"2023","unstructured":"Wright JP, Guerrero WM, Lucking JR, Bustamante-Lopez L, Monson JRT. The double-barrel wet colostomy: an alternative for urinary diversion after pelvic exenteration. Surgeon. 2023;21(6):375\u201380.","journal-title":"Surgeon."},{"issue":"6","key":"20498_CR66","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/DCR.0000000000000825","volume":"60","author":"CE Koh","year":"2017","unstructured":"Koh CE, Solomon MJ, Brown KG, Austin K, Byrne CM, Lee P, Young JM. The evolution of pelvic exenteration practice at a single center: lessons learned from over 500 cases. Dis Colon Rectum. 2017;60(6):627\u201335.","journal-title":"Dis Colon Rectum."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20498-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:02:47Z","timestamp":1791554567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":66,"alternative-id":["20498"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20498-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no financial conflicts of interest to disclose. All authors declare no conflicts of interest relevant to this manuscript. This study received no external funding.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"As a systematic review of published studies, this work did not require institutional review board approval or individual patient consent.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}